Found 29 matching trials
Compassionate Use of REGN-COV2 for the Treatment of COVID-19 N/A Compassionate Use requests will be considered for individuals who test posi...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting PHASE2 No therapeutic agent is currently approved for the treatment of SARSCoV-2 i...
Show More Location
DHR Health Institute for Research and Development
Learn More & Join Trial
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) PHASE1 The human immune system is designed to protect individuals from external so...
Show More Location
All Natural Medicine Clinic, LLC
Learn More & Join Trial
COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 N/A This is a national multicentre observational study with retrospective and p...
Show More Location
Asst-Monza Ospedale San Gerardo
Learn More & Join Trial
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 PHASE1 The primary objectives are:
Pooled Phase 3 (Cohort 1) and Phase 2 (Cohort ...
Show More Location
Regeneron Study Site
Learn More & Join Trial
COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay PHASE3 Primary Objectives:
Cohort A:
⢠To evaluate the efficacy of REGN10933+REG...
Show More Location
Regeneron Study Site
Learn More & Join Trial
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) PHASE2 The trial will develop and validate a platform for quantitative assessment ...
Show More Location
Universidade Federal de Minas Gerais
Learn More & Join Trial
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 PHASE1 The primary objectives are:
* To assess the occurrence of adverse events o...
Show More Location
Regeneron Study Site
Learn More & Join Trial
COVID-19 International Drug Pregnancy Registry N/A The objective of the COVID-19 International Drug Pregnancy Registry (COVID-...
Show More Learn More & Join Trial
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail PHASE1 This study will look to increase the donor pool for the solid organ transpl...
Show More Location
Northwell Health Organ Transplant Center
Learn More & Join Trial